• Leumas raised $2.2 million in seed funding led by Capital 2B, with participation from Capital-A and Anicut Capital.
  • The company has scaled over 120 products across India, the US, and MENA, and is launching pilot factories with pharma and food research institutions.

Deeptech startup Leumas has raised $2.2 million in seed funding to accelerate its mission of building modular, AI-driven robot factories that are set to transform pharmaceutical and wellness manufacturing.

The round was led by Capital 2B, with additional backing from Capital-A and Anicut Capital.

Leumas is reimagining manufacturing infrastructure by introducing software-defined, modular production lines that can adapt in real time to varied formulations and volumes.

This shift enables faster, traceable, and cost-effective production processes, qualities that traditional factory systems struggle to offer.

“Pharma and wellness brands today need more than just capacity. They need agility, traceability, and the ability to scale without being restricted by outdated infrastructure,” said Subhajit Biswas and Nitesh K, co-founders of Leumas.
“We are building a modern manufacturing stack that functions like software: modular, distributed, and intelligent.”

With the outsourced manufacturing market expected to exceed $400 billion by 2030, Leumas is tapping into a growing need for on-demand, personalised production in the pharma and wellness sectors.

The startup has already scaled over 120 products in India, the US, and MENA, and is partnering with pharma and food research institutions to launch pilot factories.

Investors believe Leumas’ platform, which integrates AI-powered robotics, vision-based quality control, and autonomous operations, is positioned for global relevance.

“They are solving a global challenge: manufacturing that is slow, expensive, and hard to scale,” said Vibhore Sharma, partner at Capital 2B.
Ankit Kedia, founder of Capital-A, added, “Leumas delivers a rare combination of deep technical expertise and operational clarity.”

The company’s capital-efficient model and intelligent production approach mark a significant leap in how the industry approaches scalability and compliance.

Edited by Annette George